Chelsea Goes on Survival Mode; QLT Axes 146 Staffers - July 10, 2012

Having trouble viewing this email? View in Browser.

Tuesday, July 10, 2012  |   |   |   |  Cambridge Healthtech Institute is proud to announce the production of two sequencing conferences in one convenient location. Join us this summer (August 13-15) in Providence, Rhode Island for in-depth presentations, interactive discussion groups, short courses, and networking opportunities. Registration grants you access to both meetings, allowing you to create an agenda that best fits your research needs. Register today for CHI's Seventh Annual NGx: Applying Next-Generation Sequencing ( www.healthtech.com/sqe) and the Fifth Annual Next-Generation Sequencing Data Analysis ( www.healthtech.com/sda) conference. For more information and details, visit www.healthtech.com/sequencing. ADVANCE REGISTRATION DISCOUNTS EXPIRE JULY 13!   •  Chelsea Therapeutics, Inc. (CHTP) Goes on Survival Mode More... •  QLT Inc. (QLTI) Axes 146 Staffers More... •  Janssen Pharmaceutica N.V. Enters Alliance With CureBeta for Up to $308 Million More... •  Sanofi (France) (SAN.PA) Pulls Filings for Anticoagulant Mulsevo More... •  Ranbaxy Laboratories (RANBAXY.BO) Plans to Expand Sales in the U.S. More... •  Merck KGaA (MKGAF.PK) to Portugal: Pay Bills or Lose Investment More... •  Icahn Offered to Settle With Forest Laboratories, Inc. (FRX) Before Battle More... •  Merck & Co., Inc. (MRK) Accused of Lying About Vaccine Effectiveness More... More Top News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! Oct 23 - 25, 2012 Chicago, IL (USA) Nov 6 - 8, 2012 Liverpool, England (UK) Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com. •  Clinical Trials Can Waste How Much Money? Tufts Center for the Study of Drug Development Study More... •  Sitting Less Could Extend Your Life, Pennington Biomedical Research Center Study More... •  Why Silk May Be Added to Vaccines Someday, Tufts University Study More... •  Handlebar Level Can Affect Sexual Health of Female Cyclists, Yale University School Of Medicine Study More... •  Obesity Linked to Circle of Friends, Loyola University Chicago Stritch School of Medicine Study More... •  More Proof Cranberry Juice Thwarts Infection, National Taiwan University Hospital Study More... •  Hormone Curbs Depressive-Like Symptoms in Stressed Mice, University of Texas Health Science Center Study More... •  Facebook Use Leads to Depression? University of Wisconsin Study More...   More Featured News The 26th Annual Symposium of The Protein Society August 5 - 8, 2012 www.proteinsociety.org/symposium With 14 sessions over 3.5 days covering the most diverse and current topics in the field of protein science, The Protein Society meeting has become the "must-attend" event for the leaders and future leaders in the field. Free for undergrads, with reduced registration costs for everyone and many educational workshops and unique networking opportunities, the 26th Symposium is sure to be the best yet. For more information, please click here: www.proteinsociety.org/symposium. • Pharm Country (Basking Ridge, New Jersey) ProEd Communications, Inc. Head, Global Regulatory Affairs Will be responsible and accountable for leading the continued success and growth of our regulatory business. The position requires an individual who is a strategic and critical thinker, has an intimate knowledge of drug/biologic/and preferably device approvals, has strong leadership abilities, and exhibits the flexibility necessary for working on diverse projects and traveling to client/FDA meetings. • Genetown (Cambridge, Massachusetts) Voisin Consulting Life Sciences Director - Regulatory - Drug & Biologics You will develop the activity of the VCLS Boston office. You will conduct business development activities and identify new clients as well as grow the current projects. You will be responsible for your own P&L • Biotech Bay (South San Francisco, California) Alios BioPharma, Inc. Research Associate / Associate Scientist, Virology Development and optimization of cell based antiviral assays in order to profile compounds from multiple programs. Communicate results to project teams. Proactively review the literature and introduce new approaches and technologies to the group. • Biotech Beach (Santa Monica, California) Astellas Pharma US Manager, Toxicology Provides input for the direction and management for Toxicology. Provides input for non-clinical development plans including necessary studies and their timing. Assists with preparation of protocols for non-clinical toxicology/toxicokinetic studies. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Program Manager, GMP Compound Support Leads and manages Quality activities associated with Takeda's pharmaceutical product development programs. This position ensures compliance with applicable regulations and Takeda Quality standards for pharmaceutical operations related to investigational drug product and investigational active pharmaceutical ingredients (API). Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Roche: Hoping for Continued Innovation Through Genentech • Details the contribution of each of Roche's major subsidiaries, Genentech and Chugai (along with internal development), to the company's performance. • Offers an overview of the company's new molecular entity pipeline. • Highlights reasons for the current exodus of the Pharma industry out of the "garden state" of New Jersey. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Intrexon Corporation 108 T.W. Alexander Drive PO Box 14088 Research Triangle Park, North Carolina 27709 U.S.A. Founded in 1998, Intrexon Corporation is a privately held synthetic biology company that employs modular DNA control systems to enhance capabilities, improve safety and lower cost in human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science. More Company Profiles FREE Subscription to Pharmaceutical Processing Pharmaceutical Processing magazine is the must-read information source for news of products, technologies and applications for pharmaceutical and biopharmaceutical manufacturing professionals. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.